NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

NRx Pharmaceuticals Inc (NASDAQ: NRXPW)

 
NRXPW Technical Analysis
2
As on 25th Jan 2022 NRXPW Share Price closed @ 1.47 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 5.68 & Buy for SHORT-TERM with Stoploss of 0.92 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NRXPW Share Price

Open 1.53 Change Price %
High 1.53 1 Day 0.13 9.70
Low 1.44 1 Week -0.29 -16.48
Close 1.47 1 Month -1.03 -41.20
Volume 2140 1 Year 1.22 488.00
52 Week High 15.60 | 52 Week Low 0.18
 
NASDAQ USA Most Active Stocks
XELA 0.55 34.15%
AAPL 159.78 -1.14%
AMD 111.13 -4.63%
SOFI 12.76 -4.06%
NVDA 223.24 -4.48%
MSFT 288.49 -2.66%
SNDL 0.48 4.35%
BBIG 3.01 2.73%
INTC 51.00 -1.81%
PIXY 1.55 -9.88%
 
NASDAQ USA Top Gainers Stocks
CETXW 0.02 100.00%
ZJZZT 37.50 79.86%
AKICW 0.77 60.42%
ZWZZT 22.00 46.67%
SRRA 22.68 46.23%
DBGIW 0.49 40.00%
APM 2.25 38.89%
APM 2.25 38.89%
APM 2.25 38.89%
APM 2.25 38.89%
 
NASDAQ USA Top Losers Stocks
PTRAW 0.23 -89.59%
DSKEW 0.01 -66.67%
IKNX 19.52 -42.42%
PAVMW 0.03 -40.00%
OTLKW 0.03 -40.00%
XBIOW 1.30 -35.00%
ROVRW 1.30 -34.34%
STMP 0.02 -33.33%
STMP 0.02 -33.33%
IMRNW 0.20 -33.33%
 
 
NRXPW
Daily Charts
NRXPW
Intraday Charts
Whats New @
Bazaartrend
NRXPW
Free Analysis
 
NRXPW Important Levels Intraday
RESISTANCE1.64
RESISTANCE1.59
RESISTANCE1.55
RESISTANCE1.52
SUPPORT1.42
SUPPORT1.39
SUPPORT1.35
SUPPORT1.30
 
NRXPW Target for Month January
4th UP TARGET18.31
3rd UP TARGET12.91
2nd UP TARGET9.57
1st UP TARGET6.23
1st DOWN TARGET-3.29
2nd DOWN TARGET-6.63
3rd DOWN TARGET-9.97
4th DOWN TARGET-15.37
 
NRXPW Weekly Target
4th UP TARGET1.95
3rd UP TARGET1.80
2nd UP TARGET1.70
1st UP TARGET1.61
1st DOWN TARGET1.33
2nd DOWN TARGET1.24
3rd DOWN TARGET1.14
4th DOWN TARGET0.99
 
NRXPW Target for Year 2022
4th UP TARGET32.63
3rd UP TARGET22.64
2nd UP TARGET16.46
1st UP TARGET10.28
1st DOWN TARGET-7.34
2nd DOWN TARGET-13.52
3rd DOWN TARGET-19.7
4th DOWN TARGET-29.69
 
 
NRXPW Other Details
Segment EQ
Market Capital 714611072.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NRXPW Address
NRXPW
 
NRXPW Latest News
 
Your Comments and Response on NRx Pharmaceuticals Inc
 
NRXPW Business Profile
NRX Pharmaceuticals, Inc., a clinical-stage small molecule pharmaceutical company, develops various therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company's pipeline includes medicinal candidates in Phase 2 and Phase 3 trials for COVID-19-related lung injury and acute respiratory distress. Its products include ZYESAMI, an investigational pre-commercial drug for COVID-19 related respiratory failure; and NRX-100/101, an investigational pre-commercial drug for treating bipolar depression in patients with acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware. Address: 1201 Orange Street, Wilmington, DE, United States, 19801
 
2005-2021 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service